Skip to main content
Premium Trial:

Request an Annual Quote

ABI Lays off Over 40 in Contract Sequencing Business

 NEW YORK, June 2 - Applied Biosystems laid off over 40 employees in the contract sequencing business, which was based in Rockville, MD, last week, according to a company spokesperson.


The company land has shuttered its Rockville-based sequencing business. The company plans to continue offering contract sequencing, but the bulk of the contract work they are doing in their Foster Cityplant is genotyping, said the spokesperson, Lori Murray


"We can accommodate a certain level of contract sequencing here [in Foster City, Calif.] so we didn't need the Rockville[group]," said Murray.


ABI had assumed responsibility for Celera's contract sequencing business when the company took over Celera Discovery systems in April 2002.


Last December, ABI announced that it was planning to lay off approximately 500 people. In January, the company said that no more layoffs were expected.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.